Squarepoint’s Guardant Health GH Stock Holding History

Squarepoint’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.88M	Buy	+39,200	New	+$4.26M	0.01%	1473
2026 Q1	–	Sell	-20,800	Closed	-$2.12M	–	4516
2025 Q4	$2.12M	Sell	20,800 -400	-2%	-$35.8K	﹤0.01%	2018
2025 Q3	$1.32M	Buy	21,200 +17,300	+444%	+$941K	﹤0.01%	2435
2025 Q2	$203K	Sell	3,900 -3,100	-44%	-$138K	﹤0.01%	3973
2025 Q1	$298K	Sell	7,000 -32,000	-82%	-$1.38M	﹤0.01%	3736
2024 Q4	$1.19M	Buy	+39,000	New	+$1.1M	﹤0.01%	2890
2024 Q3	–	Sell	-20,600	Closed	-$595K	–	4309
2024 Q2	$595K	Sell	20,600 -11,500	-36%	-$268K	﹤0.01%	2947
2024 Q1	$662K	Buy	+32,100	New	+$688K	﹤0.01%	2862
2021 Q3	–	Sell	-5,100	Closed	-$633K	–	3091
2021 Q2	$633K	Hold	5,100	–	–	﹤0.01%	1967
2021 Q1	$779K	Buy	+5,100	New	+$771K	﹤0.01%	1709

Other funds holding GH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Squarepoint's GH Position: Q2 2026 in Review

Squarepoint increased its Guardant Health (GH) stake by 203% in Q2 2026, buying an estimated $42.2M and bringing the position to 580,133 shares worth $87M. The position accounts for 0.1% of the portfolio, ranked #199.

Squarepoint first reported a position in GH in Q2 2019 and has held it in 18 quarters since. 598 funds tracked by Wall St. Rank hold GH as of Q2 2026.

Squarepoint held 580,133 shares of Guardant Health worth $87M as of Q2 2026.
Squarepoint bought 388,393 Guardant Health shares in Q2 2026, an estimated $42.2M.
Guardant Health made up 0.1% of Squarepoint's portfolio in Q2 2026, its #199 holding.
Squarepoint first reported a position in Guardant Health in Q2 2019 and has held it in 18 quarters since.
598 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on Squarepoint's 13F filing for Q2 2026, filed 14 Aug 2026.